Eisai Co., Ltd. (ESAIY)
OTCMKTS
· Delayed Price · Currency is USD
7.09
+0.01 (0.14%)
Apr 24, 2025, 2:28 PM EDT
Eisai Employees
Eisai had 11,067 employees as of March 31, 2024. The number of employees decreased by 9 or -0.08% compared to the previous year.
Employees
11,067
Change (1Y)
-9
Growth (1Y)
-0.08%
Revenue / Employee
$454,989
Profits / Employee
$33,789
Market Cap
8.03B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Northwest Biotherapeutics | 25 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 374 |
| CytoDyn | 9 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Eisai News
- 9 days ago - EU authorizes Eisai-Biogen's drug for treatment of early Alzheimer's disease - Reuters
- 7 weeks ago - EU regulator not updating opinion on Eisai-Biogen's Alzheimer's drug - Reuters
- 2 months ago - Eisai: Will Have No Problem Hitting Leqembi Forecasts - Seeking Alpha
- 2 months ago - Eisai Co., Ltd. (ESALF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Europe to review safety data for Eisai-Biogen Alzheimer's drug - Reuters
- 3 months ago - US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug - Reuters
- 3 months ago - Merck and Eisai's cancer drugs fail to improve overall survival in late-stage trial - Reuters
- 4 months ago - Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases - Business Wire